V004-2008 Screening compound: [(3-fluorophenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]methyl}amine

V004-2008 Screening compound: [(3-fluorophenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]methyl}amine
V004-2008 Screening compound: [(3-fluorophenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]methyl}amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-2008
[(3-fluorophenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]methyl}amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-2008

Molecular Formula

C26H27FN4O3 (C26 H27 FN4 O3)

Compound Name

[(3-fluorophenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]methyl}amine

IUPAC name

[(3-fluorophenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(morpholine-4-carbonyl)-13-oxazol-2-yl]methyl}amine

SMILES

O=C(c1coc(CN(CCc2c[nH]c3c2cccc3)Cc2cccc(F)c2)n1)N1CCOCC1

InChI

InChI=1S/C26H27FN4O3/c27-21-5-3-4-19(14-21)16-30(9-8-20-15-28-23-7-2-1-6-22(20)23)17-25-29-24(18-34-25)26(32)31-10-12-33-13-11-31/h1-7,14-15,18,28H,8-13,16-17H2

InChI Key

RHOTUCCXBOVZTN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19830310

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

462.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.154

Distribution Coefficient, logD

3.153

Water Solubility, LogSw

-3.21

Polar Surface Area

56.490

Acid Dissociation Constant (pKa)

18.49

Base Dissociation Constant (pKb)

3.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.80

V004-2008 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

Indole Derivatives (10091 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Structure:
  • Cyclic compounds
  • Mimetics
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V004-2008 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-2008?
Check Price and Availability of V004-2008, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-2008 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-2008
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-2008
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-2008 available by request